Chelsea Jin is a biostatistician with 20+ years of experience in biopharma and healthcare, including 15 years in the pharma industry to develop and deliver drugs throughout the lifecycle with a focus on phase 1 to 3 clinical trials, RWD and outcome research, as well as 8 years in academia on investigator-driven trials and observational studies, including US nationally representative epidemiological studies.

With a track record of global regulatory approvals by FDA, EMA, etc, have authored 30+ papers published in top-tier journals, such as Lancet Oncology, Blood Cancer Journal, Science Translational Medicine, Nature Communications, supported 20+ conference presentations in orals and posters presented at ASCO, AACR, ACC annual meetings, and orally presented in ASA meetings.

M.D. in Public Health, M.S. in Biophysics, and M.A. in Statistics.

All rights reserved by Chelsea Jin.